Xeris Pharmaceuticals Inc (XERS) — Free Cash Flow Generation Index

Latest as of December 2025: 0.98x

Xeris Pharmaceuticals Inc (XERS) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of $19.71 Million represents 1% of operating cash flow ($20.04 Million). See Xeris Pharmaceuticals Inc (XERS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

$19.71 Million

USD

Operating Cash Flow

$20.04 Million

USD

Capital Expenditures

$333.00K

USD

Xeris Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for Xeris Pharmaceuticals Inc across 1 annual periods. Explore Xeris Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Xeris Pharmaceuticals Inc (2025–2025)

Year-by-year Free Cash Flow Generation Index for Xeris Pharmaceuticals Inc. For the full company profile including market capitalisation, see Xeris Pharmaceuticals Inc (XERS) market capitalisation.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	0.98x	$27.93 Million	$28.63 Million	$696.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).